BlackRock Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

BlackRock Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-873	Closed	-$8K	–	3829
2016 Q1	$8K	Hold	873	–	–	﹤0.01%	3611
2015 Q4	$9K	Sell	873 -756	-46%	-$10K	﹤0.01%	3646
2015 Q3	$23K	Buy	+1,629	New	+$40K	﹤0.01%	3485

Other funds holding ZYNE

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alpine Global Management New York $658M AUM 20.22% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return